- Home
- BIAF vs USEA Comparison
BIAF vs USEA Comparison
Compare BIAF & USEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIAF
- USEA
- Stock Information
- Founded
- BIAF 2014
- USEA 2004
- Country
- BIAF United States
- USEA Greece
- Employees
- BIAF N/A
- USEA N/A
- Industry
- BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
- USEA Marine Transportation
- Sector
- BIAF Health Care
- USEA Consumer Discretionary
- Exchange
- BIAF Nasdaq
- USEA Nasdaq
- Market Cap
- BIAF 12.2M
- USEA 10.5M
- IPO Year
- BIAF 2022
- USEA N/A
- Fundamental
- Price
- BIAF $0.30
- USEA $1.49
- Analyst Decision
- BIAF Hold
- USEA Strong Buy
- Analyst Count
- BIAF 1
- USEA 1
- Target Price
- BIAF N/A
- USEA $6.00
- AVG Volume (30 Days)
- BIAF 11.2M
- USEA 200.9K
- Earning Date
- BIAF 08-13-2025
- USEA 08-05-2025
- Dividend Yield
- BIAF N/A
- USEA 2.66%
- EPS Growth
- BIAF N/A
- USEA N/A
- EPS
- BIAF N/A
- USEA N/A
- Revenue
- BIAF $8,809,228.00
- USEA $42,595,000.00
- Revenue This Year
- BIAF N/A
- USEA N/A
- Revenue Next Year
- BIAF $20.00
- USEA $11.62
- P/E Ratio
- BIAF N/A
- USEA N/A
- Revenue Growth
- BIAF 78.40
- USEA N/A
- 52 Week Low
- BIAF $0.16
- USEA $1.00
- 52 Week High
- BIAF $2.99
- USEA $2.78
- Technical
- Relative Strength Index (RSI)
- BIAF 50.96
- USEA 55.20
- Support Level
- BIAF $0.22
- USEA $1.40
- Resistance Level
- BIAF $0.46
- USEA $1.57
- Average True Range (ATR)
- BIAF 0.04
- USEA 0.13
- MACD
- BIAF 0.01
- USEA 0.00
- Stochastic Oscillator
- BIAF 30.51
- USEA 29.17
About BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About USEA United Maritime Corporation
United Maritime Corp operates as a shipping company currently specializing in the seaborne transportation of dry bulk commodities. It currently operates one LR2 tanker vessel and three Capesize dry bulk vessels, two Kamsarmax dry bulk vessels, and three Panamax dry bulk vessels, with an aggregate cargo-carrying capacity of approximately 1,004,289 dwt.